BioSpace News Archive

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper , chairman, president and chief executive officer, will participate in a virtual fireside chat at the BofA Securities 2020 Health Care Conference on Wednesday, May 13, 2020 , at 8:20 a.m. (EST) . You can access the webc

OssDsign announces the appointment of Eric Patermo as VP of Sales for OssDsign USA, Inc, a wholly owned subsidiary of OssDsign AB.

First-in-human trial will test the safety, pharmacokinetics and preliminary efficacy of microRNA therapeutic candidate INT-1B3

Company to test LAU-7b’s dual pro-resolving inflammation and antiviral properties against COVID-19

Mesoblast Limited announced that the first patients have been dosed in the 300-patient randomized placebo-controlled Phase 2/3 trial in the United States of Mesoblast’s allogeneic cellular medicine remestemcel-L in COVID-19 infected patients with moderate to severe acute respiratory distress syndrome on ventilator support.

New antagonists targeting misfolded RACK1 prevent dysfunctional protein aggregates from forming and restore normal function

ChromaDex highlights additional clinical and preclinical research strengthening science and understanding behind Niagen®

CVS Health Corporation announced operating results for the three months ended March 31, 2020.

Ra Medical Systems, Inc. announces that it will report first quarter 2020 financial results and provide a business update after market close on Wednesday, May 13, 2020.

U.S. Food and Drug Administration (FDA) Accepted for Review a Supplemental New Drug Application (sNDA) for RECARBRIO in Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia in February 2020